PHATHOM PHARMACEUTICALS INC
PHATNASDAQ🏆 #2841 by market capEarnings Oct 28US Equity
$7.36▼ $0.00 (−0.05%)
LiveTrack PHAT
Get earnings, price moves & breaking news on Telegram
24h▼ 0.1%
7d▲ 5.4%
14d▼ 4.3%
30d▼ 23.0%
ytd▼ 55.7%
1y▼ 37.4%
🏦Market Cap
$595M
Small Cap
📈Revenue Growth (YoY)
+216.9%
High Growth
📊Gross Margin
82.9%
High
💵FCF Margin
-15.3%
Thin
⚖️P/S Ratio
2.5x
Cheap
Otter Score
60
Fair
PHATHOM PHARMACEUTICALS INC
PHATAnalyst Ratings
Price
$7.36
Total
9
Raised
1
Lowered
0
Avg PT
$17.60
H / L
$22 / $10
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Overweight | 2026-08-17 | $14.00 | +90.30% |
Guggenheim | Reiterated | Buy | 2026-07-31 | $22.00 | +199.10% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-31 | — | — |
Needham | Reiterated | Buy | 2026-07-30 | $22.00 | +199.10% |
Craig-Hallum | Reiterated | Buy | 2025-06-09 | $20.00 | +171.90% |
Goldman Sachs | Reiterated | Neutral | 2025-05-02 | $12.00 | +63.10% |
Evercore ISI Group | Upgraded | In Line → Outperform | 2023-05-11 | — | — |
BMO Capital | Reiterated | Outperform | 2023-03-01 | $35.00 | +375.80% |
Jefferies | Reiterated | Buy | 2022-10-21 | — | — |
Institution
Barclays
Reiterated · Overweight · 2026-08-17
$14.00
+90.30%
Guggenheim
Reiterated · Buy · 2026-07-31
$22.00
+199.10%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-31
—
—
Needham
Reiterated · Buy · 2026-07-30
$22.00
+199.10%
Craig-Hallum
Reiterated · Buy · 2025-06-09
$20.00
+171.90%
Goldman Sachs
Reiterated · Neutral · 2025-05-02
$12.00
+63.10%
Evercore ISI Group
Upgraded · In Line → Outperform · 2023-05-11
—
—
BMO Capital
Reiterated · Outperform · 2023-03-01
$35.00
+375.80%
Jefferies
Reiterated · Buy · 2022-10-21
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space